DOI: https://doi.org/10.26641/2307-0404.2018.3(part1).142376

Influence of compliance patients with a combination of type 2 diabetes and chronic gastritis on features of course and treatment

Y. S. Sirchak, S. V. Patskun

Abstract


Diabetes mellitus is a systemic metabolic disease that can affect most of the bodily systems, including the gastrointestinal tract. Some studies report a higher prevalence of HP infection in people with diabetes. A healthy diet, regular physical activity, support of normal body weight and avoiding tobacco use can help prevent or delay the onset of DM 2 type. The purpose of the study - to evaluate the peculiarities of the clinical course and effectiveness of treatment of DM type 2 and chronic gastritis (CG) depending on the presence of higher education in patients. 46 HP positive patients with a combination of CG and type 2 DM were examined, the average age of patients was 55.4±1.3 years. Patients were divided into 2 groups, depending on the presence or absence of higher education, so that 23 (50%) patients with higher education were included in group I, whereas in the II group – 23 (50%) patients with secondary education. The Morisky-Green scale was tested to determine the patient's compliance. Results. Insulin resistance depends on the presence of HP in the body and its eradication subsequently leads to an improvement in insulin sensitivity. According to the results obtained, patients in group I (with higher education) have a higher degree of adherence to treatment, namely, the average score of compliance in the I group was 0.61±0.15 points, and in the II group – 2.74±0.24 points. Hence, the presence of higher education in a patient contributes to better adherence to treatment. Improvement of insulin resistance after eradication of HP in patients with type 2 DM and CG, and these changes are somewhat more significant in patients with higher education.


Keywords


chronic gastritis; type 2 diabetes mellitus; compliance

References


Leonardo HE, Rocco M, Zagari, Franco B. Epide­miology of Helicobacter pylori Infection. J Helicobacter. 2014;1(19):1-5.

International Diabetes Federation. 2013 Sixth edition. Available from: https://www.idf.org/sites/de­fault/files/EN_6E_Atlas_Full_0.pdf. Accessed 19 Feb 2016.

Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Phar­macol Ther. 2013;38:329-42.

Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Countries 2010;30:22-6.

WHO. Fact sheet no. 312: Diabetes. Geneva, WHO; 2013.

World Health Organization. Global Health Esti­mates: Deaths by Cause, Age, Sex and Country, 2000-2012. Geneva, WHO; 2014.


GOST Style Citations


  1. Epidemiology of Helicobacter pylori Infection / H.E. Leonardo, M. Rocco, Zagari, B. Franco // J. Helico­bacter. – 2014. – Vol. 19, N 1. – P. 1-5.
  2. International Diabetes Federation.; 2013 Sixth edi­tion. Available from: https://www.idf.org/sites/de­fault/files/EN_6E_Atlas_Full_0.pdf. Accessed 19 Feb 2016.
  3. Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases / A. Sonnenberg // Aliment Pharmacol Ther. – 2013. – Vol. 38. – P. 329-342.
  4. Type 2 diabetes mellitus: a risk factor for Heli­cobacter pylori infection: a hospital based case-control study / B.R. Devrajani, S.Z. Shah, A.A. Soomro, T. Dev­rajani // Inter. J. Diabetes Dev Countries. – 2010. – Vol. 30. – P. 22-26.
  5. WHO. Fact sheet no. 312: Diabetes. – Geneva: WHO, 2013.
  6. World Health Organization. Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000-2012. – Geneva: WHO, 2014.